SLC12A5 and pancreatic adenocarcinoma: As displayed in Figures 4(a)–4(c), SLC12A5 had higher expression in advanced tumor stages of COAD, ESCA, and KIRC, while the lower the expression level of SLC12A5, the more advanced stage of PAAD, READ, and TGCT (Figures 4(d)–4(f)).